ArticleBMC microbiology2026
Harnessing Bacillus velezensis for enhanced protease biosynthesis: optimization, purification, and kinetic profiling.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genome-Guided Dissection of ser and shlB Uncovers Multifactorial Virulence Mechanisms of Serratia marcescens PXG6 in Plutella xylostella.Environmental microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial proteases represent critical biocatalysts for industrial applications, yet optimizing their production remains challenging. This study isolated and characterized a high-yield protease-producing bacterium from environmental sources and systematically optimized production parameters. Among 124 bacterial isolates screened from six environmental sources, poultry waste exhibited the highest microbial diversity, yielding 63 morphologically diverse isolates. The most potent proteolytic isolate, P15, was identified through 16 S rRNA gene sequencing as Bacillus velezensis AZH3S (GenBank accession PX417380), sharing 99% sequence similarity with B. amyloliquefaciens. Initial screening of eight culture media identified glucose-casein-yeast extract medium as optimal, producing 442 U/mL protease activity. Time-course analysis revealed maximum enzyme production at 24 h (420 U/mL), with yield coefficients increasing to 480 U/g biomass in late stationary phase. Carbon and nitrogen source optimization demonstrated that starch (470 U/mL) and peptone (480 U/mL) were superior substrates. Response surface methodology employing Box-Behnken design across five variables (starch, peptone, pH, temperature, agitation speed) generated a highly predictive model (R² = 0.99) identifying agitation speed as the most influential parameter. Optimized conditions (9.84 g/L starch, 5.46 g/L peptone, pH 7.5, 33.1 °C, 244 rpm) achieved 1160.3 ± 9.20U/mL protease activity, representing a 2.80-fold improvement over initial production. Three-step purification achieved 5.82-fold enrichment with 32.0% yield. The purified enzyme exhibited a molecular mass of approximately 20 kDa with exceptional substrate affinity (Km = 0.207 mM, Vmax = 39.8 µmol/min), following classical Michaelis-Menten kinetics.These findings establish a robust bioprocess for industrial-scale protease production with significant biotechnological potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.